HUTCHMED (China) Limited

As of December 31, 2025, HUTCHMED (China) Limited carries a market capitalization of 17.73B, placing it among publicly traded companies globally. Its enterprise value stands at 7.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

HUTCHMED (China) Limited's next confirmed earnings release is scheduled for March 4, 2027.

As of December 31, 2025, HUTCHMED (China) Limited has 859.74M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, HUTCHMED (China) Limited maintains a current ratio of 4.96, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, HUTCHMED (China) Limited's stock has declined approximately 6.21% over the past 52 weeks. The 50-day moving average sits at 21.22, while the 200-day moving average is 20.84.

As of December 31, 2025, HUTCHMED (China) Limited holds 10.64B in cash and equivalents against 761.80M in total debt, resulting in a net debt position of 169.88M. Total book value stands at 9.63B, with working capital of 9.74B providing operational flexibility.